Guidelines for indicating, obtaining, processing, and evaluating kidney transplant biopsies;Recomendaciones para la indicación, obtención, procesamiento y evaluación de biopsias en el trasplante renal

Nefrologia

Volumn 28, Issue 4, 2008, Pages 385-396

  Seron D ^a   Anaya, F ^b   Marcen R ^c   Del Moral, R García ^d   Vazquez Martul E ^e   Alarcon A ^f   Andres A ^g   Burgos, D ^h   Capdevila, L ⁱ   Molina, M González ^h   Jimenez C ^j   Morales, J M ^g   Oppenheimer, F ^k   Pallardo L ^l   Fructuoso, A Sánchez ^m  

^a HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

^b HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

^c HOSPITAL RAMÓN Y CAJAL   (Spain)

^d HOSPITAL UNIVERSITARIO VIRGEN DE LAS NIEVES   (Spain)

^e HOSPITAL JUAN CANALEJO   (Spain)

^f HOSPITAL UNIVERSITARIO SON ESPASES   (Spain)

^g HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

^h HOSPITAL REGIONAL UNIVERSITARIO DE MÁLAGA   (Spain)

ⁱ HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^j HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

^k HOSPITAL CLÍNIC   (Spain)

^l HOSPITAL UNIVERSITARIO DR PESET   (Spain)

^m HOSPITAL CLÍNICO SAN CARLOS   (Spain)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BIOPSY; CONSENSUS DEVELOPMENT; DONOR; HUMAN; KIDNEY TRANSPLANTATION; METHODOLOGY; PATHOLOGY; PRACTICE GUIDELINE;

BIOPSY; HUMANS; KIDNEY TRANSPLANTATION; PRACTICE GUIDELINES AS TOPIC; TISSUE DONORS;

EID: 51249093901     PISSN: 02116995     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (87)

1. Valentín MO, Garrido G, Martín Escobar E, De la Rosa G, Mahillo B. Domínguez-Gil B y cols. [Donation and kidney transplantation activity in Spain. 2006]. Nefrología 2007; 27 (4): 434-8.
2. El-Husseini A, Sabry A, Zahran A, Shoker A, Can donor implantation renal biopsy predict long-term renal allograft outcome? Am J Nephrol 2007; 27 (2): 144-51.
3. Serón D, Moreso F. Protocol biopsies in renal transplantation: prognostic value of structural monitoring, Kidney int 2007; 72 (6): 690-7.
4. Moreso F, Serón D. Blanco J, Suñer M, De Gracia R, Sánchez-Plumed J y cols. Indicación, procesamiento y diagnóstico de biopsias realizadas en España en pacientes con trasplante renal durante el año 2004, Presentado en el Congreso de la Sociedad Española de Nefrología, Cádiz, España, Octubre de 2007 [Póster #141].
5. Gaber LW, Gaber AO, Tolley EA, Hathaway DK, Prediction by postrevascularlzation biopsies of cadaveric kidney allografts of rejection, graft loss, and preservation nephropathy, Transplantation 1992; 53 (6): 1219-25.
6. Lee S, Kim JS, Cho MH, Chae DW, Kim HJ, Nam ES y cols. Relationship of renal implantation biopsies and acute rejection during the immediate posttransplantation period. Transplant Proc 1998; 30 (7): 3070-1.
7. Oberbauer R, Rohrmoser M, Regele H, Muhlbacher F, Mayer G. Apoptosis of tubular epithelial cells in donor kidney biopsies predicts early renal allograft function. J Am Soc Nephrol 1999; 10 (9): 2006-13.
8. Gaber LW, Moore LW, Alloway RR, Amiri MH, Vera SR, Gaber AO. Glomerulosclerosis as a determinant of posttransplant function of older donor renal allografts. Transplantation 1995; 60 (4): 334-9.
9. Karpinski J. Lajoie G, Cattran D, Fenton S, Zaltzman J, Cardella C y cols. Outcome of kidney transplantation from high-risk donors is determined by both structure and function, Transplantation 1999; 67(8): 1162-7.
10. Eapen G, Hinduja A, Abraham G, Kuruvilla S, Panicker V, Thirumalai R y cols. Does implantation biopsy help in predicting renal allograft management and outcome? Transplant Proc 2000; 32 (7): 1795.
11. Kuypers DR, Chapman JR, O'Connell PJ, Allen RD, Nankivell BJ, Predictors of renal transplant histology at three months, Transplantation 1999; 67 (9): 1222-30.
12. Bosmans JL, Woestenburg A, Ysebaert DK, Chapelle T. Helbert MJ, Corthouts R y cols. Fibrous intimal thickening at implantation as a risk factor for the outcome of cadaveric renal allografts, Transplantation 2000; 69 (11): 2388-94.
13. Randhawa PS, Minervini Mi, Lombardero M, Duquesnoy R, Fung J, Shapiro R y cols. Biopsy of marginal donor kidneys: correlation of histologic findings with graft dysfunction, Transplantation 2000; 69 (7): 1352-7.
14. Cicciarelli J, Cho Y, Mateo R, El-Shahawy M, Iwaki Y, Selby R, Renal biopsy donor group: the influence of glomerulosclerosis on transplant outcomes, Transplant Proc 2005; 37(2): 712-3.
15. Howie AJ, Ferreira MA, Lipkin GW, Adu D. Measurement of chronic damage in the donor kidney and graft survival, Transplantation 2004; 77 (7): 1058-65.
16. Ugarte R, Kraus E, Montgomery RA, Burdick JF, Ratner L, Haas M y cols. Excellent outcomes after transplantation of deceased donor kidneys with high terminal creatinine and mild pathologic lesions, Transplantation 2005; 80 (6): 794-800.
17. Nankivell BJ, Fenton-Lee CA, Kuypers DR, Cheung E, Allen RD, O'Connell PJ y cols. Effect of histological damage on long-term kidney transplant outcome, Transplantation 2001; 71 (4): 515-23.
18. Chapman JR. Longitudinal analysis of chronic allograft nephropathy: clinicopathologic correlations, Kidney Int Suppl 2005; (99): S108-12.
19. Nankivell BJ, Borrows RJ, Fung CL, O'Connell PJ, Chapman JR, Allen RD, Delta analysis of posttransplantation tubulolnterstitial damage. Transplantation 2004; 78 (3): 434-41.
20. Cosio FG, Grande JR Larson TS, Gloor JM, Velosa JA, Textor SC y cols. Kidney allograft fibrosis and atrophy early after living donor transplantation, Am J Transplant 2005; 5(5): 1130-6.
21. Lu AD, Desal D, Myers BD, Dafoe DC, Alfrey EJ, Severe glomerular sclerosis is not associated with poor outcome after kidney transplantation, Am J Surg 2000; 180 (6): 470-4.
22. Vazquez Martul E, Veiga Barreiro A, Importance of kidney biopsy in graft selection, Transplant Proc 2003; 35 (5): 1658-60.
23. Epstein M. Aging and the kidney, J Am Soc Nephrol 1996; 7 (8): 1106-22.
24. Baylls C, Corman B. The aging kidney: insights from experimental studies, J Am Soc Nephrol 1998; 9 (4): 699-709.
25. Rao KV, Kasiske BL, Odlund MD, Ney AL, Andersen RC, Influence of cadaver donor age on posttransplant renal function and graft outcome, Transplantation 1990; 49 (1): 91-5.
26. Terasaki Pl, Gjertson DW, Cecka JM, Takemoto S, Cho YW. Significance of the donor age effect on kidney transplants, Clin Transplant 1997; 11 (5 Pt 1): 366-72.
27. Remuzzi G, Cravedi P. Perna A, Dimitrov BD, Turturro M, Locatelli G y cols. Long-term outcome of renal transplantation from older donors, N Engl J Med 2006; 354 (4): 343-52.
28. Remuzzi G, Grinyo J, Ruggenenti P, Beatini M, Cole EH, Milford EL y cols.. Early experience with dual kidney transplantation in adults using expanded donor criteria, Double Kidney Transplant Group (DKG). J Am Soc Nephrol 1999; 10 (12): 2591-8.
29. Lopes JA, Moreso F, Riera L, Carrera M, Ibernon M, Fulladosa X y cols. Evaluation of pre-implantation kidney biopsies: comparison of Banff criteria to a morphometric approach. Kidney Int 2005; 67 (4): 1595-600.
30. Solez K. Axelsen RA, Benediktsson H, Burdick JF, Cohen AH, Colvin RB y cols. International standardization of criteria for the histologic diagnosis of renal allograft rejection: the Banff working classification of kidney transplant pathology, Kidney Int 1993; 44 (2): 411-22.
31. Racusen LC, Solez K, Colvin RB, Bonsib SM, Castro MC, Cavallo T y cols. The Banff 97 working classification of renal allograft pathology, Kidney Int 1999; 55 (2): 713-23.
32. Racusen LC, Colvin RB, Solez K, Mihatsch MJ, Halloran PF, Campbell PM y cols. Antibody-mediated rejection criteria -an addition to the Banff 97 classification of renal allograft rejection. Am J Transplant 2003; 3 (6): 708-14.
33. Solez K, Colvin RB, Racusen LC, Sis B, Halloran PF, Birk PE y cols. Banff '05 Meeting Report: differential diagnosis of chronic allograft injury and elimination of chronic allograft nephropathy («CAN»), Am J Transplant 2007; 7 (3): 518-26.
34. Colvin RB, Cohen AH, Saiontz C, Bonsib S, Buick M, Burke B y cols. Evaluation of pathologic criteria for acute renal allograft rejection: reproducibility, sensitivity, and clinical correlation, J Am Soc Nephrol 1997; 8 (12): 1930-41.
35. Mueller A, Schnuelle P, Waldherr R, Van der Woude FJ. Impact of the Banff '97 classification for histological diagnosis of rejection on clinical outcome and renal function parameters after kidney transplantation, Transplantation 2000; 69 (6): 1123-7.
36. Nankivell BJ, Borrows RJ, Fung CL, O'Connell PJ, Allen RD, Chapman JR. The natural history of chronic allograft nephropathy, N Engl J Med 2003; 349(24): 2326-33.
37. Rush DN, Jeffery JR, Gough J, Sequential protocol biopsies in renal transplant patients, Cllnico-pathological correlations using the Banff schema. Transplantation 1995; 59 (4): 511-4.
38. Nankivell BJ, Borrows RJ, Fung CL, O'Connell PJ, Allen RD, Chapman JR, Natural history, risk factors, and impact of subclinical rejection in kidney transplantation, Transplantation 2004; 78 (2): 242-9.
39. Mengel M, Gwinner W, Schwarz A, Bajeskl R, Franz I, Brocker V y cols. Infiltrates in protocol biopsies from renal allografts. Am J Transplant 2007; 7(2): 356-65.
40. Legendre C, Thervet E, Skhiri H, Mamzer-Bruneel MF, Cantarovich F, Noel LH y cols. Histologic features of chronic allograft nephropathy revealed by protocol biopsies in kidney transplant recipients. Transplantation 1998; 65 (11): 1506-9.
41. Moreso F, Ibernon M, Goma M. Carrera M, Fulladosa X, Hueso M y cols. Subclinical rejection associated with chronic allograft nephropathy in protocol biopsies as a risk factor for late graft loss. Am J Transplant 2006; 6 (4): 747-52.
42. Choi BS, Shin MJ, Shin SJ, Kim YS, Choi YJ, Moon IS y cols. Clinical significance of an early protocol biopsy in living-donor renal transplantation: ten-year experience at a single center. Am J Transplant 2005; 5 (6): 1354-60.
43. Serón D, Moreso F, Fulladosa X, Hueso M, Carrera M, Grinyo JM. Reliability of chronic allograft nephropathy diagnosis in sequential protocol biopsies, Kidney Int 2002; 61 (2): 727-33.
44. Fulladosa X, Moreso F, Torras J, Hueso M, Grinyo JM, Serón D. Structural and functional correlations in stable renal allografts. Am J Kidney Dis 2003; 41 (5): 1065-73.
45. Isoniemi HM, Krogerus L, Von Willebrand E, Taskinen E, Ahonen J, Hayry R Histopathological findings in well-functioning, long-term renal allografts, Kidney Int 1992; 41 (1): 155-60.
46. Yilmaz S, Tomlanovich S, Mathew T, Taskinen E, Paavonen T, Navarro M y cols. Protocol core needle biopsy and histologic Chronic Allograft Damage Index (CADI) as surrogate end point for long-term graft survival in multicenter studies, J Am Soc Nephrol 2003; 14(3): 773-9.
47. Dimeny E, Wahlberg J, Larsson E, Fellstrom B, Can histopathological findings in early renal allograft biopsies identify patients at risk for chronic vascular rejection? Clin Transplant 1995; 9 (2): 79-84.
48. Serón D, Moreso F, Bover J, Condom E, Gil-Vernet S, Canas C y cols. Early protocol renal allograft biopsies and graft outcome. Kidney Int 1997; 51 (1): 310-6.
49. Serón D, Moreso F, Ramón JM, Hueso M, Condom E, Fulladosa X y cols. Protocol renal allograft biopsies and the design of clinical trials aimed to prevent or treat chronic allograft nephropathy. Transplantation 2000; 69 (9): 1849-55.
50. Cosio FG, Grande JP Wadei H, Larson TS, Griffin MD, Stegall MD. Predicting subsequent decline in kidney allograft function from early surveillance biopsies, Am J Transplant 2005; 5(10): 2464-72.
51. Shlshido S, Asanuma H, Nakai H, Mori Y, Satoh H, Kamimaki I y cols. The impact of repeated subclinical acute rejection on the progression of chronic allograft nephropathy, J Am Soc Nephrol 2003; 14(4): 1046-52.
52. Rush D. Nickerson R Gough J, McKenna R, Grimm R Cheang M y cols. Beneficial effects of treatment of early subclinical rejection: a randomized study, J Am Soc Nephrol 1998; 9(11): 2129-34.
53. Buehrlg CK, Lager DJ, Stegall MD, Kreps MA, Kremers WK, Gloor JM y cols. Influence of surveillance renal allograft biopsy on diagnosis and prognosis of polyomavirus-assoclated nephropathy, Kidney Int 2003; 64(2): 665-73.
54. Lachenbruch PA, Rosenberg AS, Bonvini E, Cavaille-Coll MW, Colvin RB. Biomarkers and surrogate endpoints in renal transplantation: present status and considerations for clinical trial design. Am J Transplant 2004; 4 (4): 451-7.
55. Larson TS, Dean PG, Stegall MD, Griffin MD, Textor SC, Schwab TR y cols. Complete avoidance of calcineurin inhibitors in renal transplantation: a randomized trial comparing sirolimus and tacrolimus. Am J Transplant 2006; 6 (3): 514-22.
56. Vincenti F, Larsen C, Durrbach A, Wekerle T, Nashan B, Blancho G y cols. Costimulation blockade with belatacept in renal transplantation. N Engl J Med2005; 353 (8): 770-81.
57. Solez K, Vincenti F, Filo RS, Histopathologic findings from 2-year protocol biopsies from a US multicenter kidney transplant trial comparing tarolimus versus cyclosporine: a report of the FK506 Kidney Transplant Study Group. Transplantation 1998; 66 (12): 1736-40.
58. Flechner SM, Kurian SM, Solez K, Cook DJ, Burke JT, Rollin H y cols. De novo kidney transplantation without use of calcineurin inhibitors preserves renal structure and function at two years. Am J Transplant 2004; 4 (11): 1776-85.
59. Morales J, Andrés A, Pallandó L, Capdevila L, Campistol J, Gil Vernet J y cols. Trasplante renal en pacientes de edad avanzada con un riñon de donante añoso, Nefrología 1998; 18 (Supl. 5): 32-47.
60. Rosengard BR, Feng S, Alfrey EJ, Zaroff JG, Emond JC, Henry ML y cois, Report of the Crystal City meeting to maximize the use of organs recovered from the cadaver donor, Am J Transplant 2002; 2 (8): 701-11.
61. Whiting JF. Clinical and economic outcomes of the use of expanded criteria donors in renal transplantation, Semin Dial 2000; 13 (5): 316-9.
62. Metzger RA, Delmonico FL, Feng S, Port FK, Wynn JJ, Merion RM. Expanded criteria donors for kidney transplantation, Am J Transplant 2003; 3 Supl. 4: 114-25.
63. Ojo AO, Leichtman AB, Punch JD, Hanson JA, Dickinson DM, Wolfe RA y cols. Impact of pre-existing donor hypertension and diabetes mellitus on cadaveric renal transplant outcomes. Am J Kidney Dis 2000; 36(1): 153-9.
64. Scheiden R, Sand J, Tanous AM, Knolle U, Capesius C, Wagnon MC y cols. Accuracy of frozen section diagnoses of breast lesions after Introduction of a national programme in mammographic screening. Histopathology 2001; 39 (1): 74-84.
65. Kok, LP Boon ME: Microwawes for the art of microscopy Coulomb Press Leyden, Leyden, 2003, ISBN 90-71421-41-4.
66. Junta de Andalucía, Consejería de Salud. Proceso asistencial: Tratamiento sustitutivo de la insuficiencia renal crónica: diálisis y trasplante renal (consultado en http://www.juntadeandalucla, es/salud/procesos/documentos.asp?idp=154 el 10 de diciembre del 2007).
67. Solez K, Colvin RB, Racusen LC, Haas M, Sis B, Mengel M y cols. Banff' 07 classification of renal allograft pathology: updates and future directions, Am J Transplant 2008; 8 (4): 753-60.
68. Perico N, Cattaneo D, Sayegh MH, Remuzzi G. Delayed graft function in kidney transplantation, Lancet 2004; 364 (9447): 1814-27.
69. Koning OH, Ploeg RJ, Van Bockel JH, Groenewegen M, Van der Woude FJ, Persljn GG y cols. Risk factors for delayed graft function in cadaveric kidney transplantation: a prospective study of renal function and graft survival after preservation with University of Wisconsin solution in multi-organ donors, European Multicenter Study Group. Transplantation 1997; 63 (11): 1620-8.
70. European Best Practice Guidelines for Renal Transplantation (part 1), Nephrol Dial Transplant 2000; 15 Supl. 7: 1-85.
71. Vadivel N, Tullius SG, Chandraker A. Chronic allograft nephropathy, Semin Nephrol 2007; 27 (4): 414-29.
72. Paul LC, Hayry R Foegh M, Dennis MJ, Mihatsch MJ, Larsson E y cols. Diagnostic criteria for chronic rejection/accelerated graft atherosclerosis in heart and kidney transplants: joint proposal from the Fourth Alexis Carrel Conference on Chronic Rejection and Accelerated Arteriosclerosis in Transplanted Organs. Transplant Proc 1993; 25 (2): 2022-3.
73. Dudley C, Pohanka E, Riad H, Dedochova J. Wijngaard P, Sutter C y cols. Mycophenolate mofetil substitution for cyclosporine a in renal transplant recipients with chronic progressive allograft dysfunction: the «creeping creatinine» study, Transplantation 2005; 79 (4): 466-75.
74. Vidhun J, Masciandro J, Varlch L, Salvatierra O, Jr., Sarwal M. Safety and risk stratification of percutaneous biopsies of adult-sized renal allografts in infant and older pediatric recipients, Transplantation 2003; 76 (3): 552-7.
75. Nicholson ML, Wheatley TJ, Doughman TM, White SA, Morgan JD, Veitch PS y cols. A prospective randomized trial of three different sizes of core-cutting needle for renal transplant biopsy, Kidney Int 2000; 58(1): 390-5
76. Kim D, Kim H, Shin G, Ku S, Ma K, Shin S y cols. A randomized, prospective, comparative study of manual and automated renal biopsies, Am J Kidney Dis 1998; 32 (3): 426-31.
77. Mauiyyedi S, Crespo M, Collins AB, Schneeberger EE, Pascual MA, Saidman SL y cols. Acute humoral rejection in kidney transplantation: II. Morphology, immunopathology, and pathologic classification, J Am Soc Nephrol 2002; 13 (3): 779-87.
78. Mauiyyedi S, Pelle PD, Saidman S, Collins AB, Pascual M, Tolkoff-Rubin NE y cols. Chronic humoral rejection: identification of antibody-mediated chronic renal allograft rejection by C4d deposits in peritubular capillaries, J Am Soc Nephrol 2001; 12 (3): 574-82.
79. Regele H, Bohmig GA, Habicht A, Gollowitzer D, Schillinger M, Rockenschaub S y cols. Capillary deposition of complement split product C4d in renal allografts is associated with basement membrane injury in peritubular and glomerular capillaries: a contribution of humoral immunity to chronic allograft rejection. J Am Soc Nephrol 2002; 13 (9): 2371-80.
80. Seemayer CA, Gaspert A, Nickeleit V, Mihatsch MJ, C4d staining of renal allograft biopsies: a comparative analysis of different staining techniques, Nephrol Dial Transplant 2007; 22 (2): 568-76.
81. Serón D, O'Valle F, Moreso F, Goma M, Hueso M, Grinyo JM y cols. Immunophenotype of Infiltrating cells in protocol renal allograft biopsies from tacrolimus-versus cyclosporine-treated patients, Transplantation 2007; 83 (5): 649-52.
82. Moreso F, Serón D, O'Valle F, Ibernon M, Goma M, Hueso M y cols. Immunephenotype of glomerular and interstitial infiltrating cells in protocol renal allograft biopsies and histological diagnosis, Am J Transplant 2007; 7 (12): 2739-47.
83. Kayler LK, Lakkis FG, Morgan C, Basu A, Blisard D, Tan HP y cols. Acute cellular rejection with CD20-positlve lymphoid clusters in kidney transplant patients following lymphocyte depletion, Am J Transplant 2007; 7 (4): 949-54.
84. Grlmbert R Mansour H, Desvaux D, Roudot-Thoraval F, Audard V, Dahan K y cols. The regulatory/cytotoxic graft-infiltrating T cells differentiate renal allograft borderline change from acute rejection, Transplantation 2007; 83 (3): 341-6.
85. Alta K, Yamaguchi Y, Horita S, Ohno M, Tanabe K, Fuchinoue S y cols. Thickening of the peritubular capillary basement membrane Is a useful diagnostic marker of chronic rejection in renal allografts, Am J Transplant 2007; 7 (4): 923-9.
86. Ivanyi B, Kemeny E, Szederkenyl E, Marofka F, Szenohradszky P. The value of electron microscopy in the diagnosis of chronic renal allograft rejection, Mod Pathol 2001; 14(12): 1200-8.
87. Oberbauer R, Segoloni G, Camplstol JM, Kreis H, Mota A, Lawen J y cols. Early cyclosporine withdrawal from a sirollmus-based regimen results in better renal allograft survival and renal function at 48 months after transplantation, Transpl Int 2005; 18(1): 22-8.